U.S., March 4 -- ClinicalTrials.gov registry received information related to the study (NCT07444788) titled 'Acute Effects of Intravenous 5-MeO-DMT in Healthy Participants' on Feb. 06.
Brief Summary: Participation in this study lasts approximately two weeks and includes three on-site study visits: a screening visit (approximately 2 hours), a study drug administration visit (approximately 4 hours), and a follow-up visit approximately one week later (approximately 2 hours).
If participants decide to take part in the study and meet the inclusion and exclusion criteria, they will be randomly assigned to one of two groups: an experimental group or a control group. Participants will not be informed of your group assignment. Participants in the ...